Del Medical Systems Group Signs Exclusive Agreement to Sell Gemini DR Flat Panels in the Americas.

Company to Showcase DR Flat Panels at AHRA 2008, held July 27-31

FRANKLIN PARK, Ill. -- Del Global Technologies Corp. (OTCBB: DGTC) ("Del Global" or "the Company") today announced that it has signed an exclusive agreement with New Medical Imaging (NMI) of Taiwan, ROC, to sell and market NMI's Gemini family of full-field, portable DR flat panels in the Americas. Del Medical will feature the Gemini flat panels at booth #738 at the AHRA 2008 Annual Meeting and Exposition, held July 27-31, 2008.

"The Gemini products clearly demonstrate what Del is all about. We're offering the latest flat panel technology to our customers in a way that makes sense for them," said Dennis Runyan, VP of Sales. He continued, "We understand the sizeable investments our customers have already made in our products. With the introduction of the Gemini DR flat panels, we are offering an exclusive, cost-effective upgrade option that allows healthcare providers to take the next step in digital radiography while maintaining their current equipment."

The Gemini flat panels are easily integrated into Del's tables, which allows existing customers to upgrade or field retrofit their digital imaging systems. All of the Gemini products feature the latest flat panel technology and are DICOM compatible. Lightweight and portable, these flat panels facilitate multiple applications, while ensuring patient comfort and safety. Sharp, clear images appear on the screen in a matter of seconds resulting in significant workflow benefits.

The Gemini 1000[TM], Gemini 1400[TM] and Gemini 1700[TM] models are available immediately through a select Del dealer network.

ABOUT NEW MEDICAL IMAGING

New Medical, is a Taiwan based medical technology company born of a government initiative and supported by the high tech industries in Taiwan that produce Flat Panel Televisions, Computer Memory and Microprocessors for the world. New Medical's HDDR technology is the newest DR technology released to date. Hundreds of devices based on this technology are currently in use throughout Asia. The company's website is www.nmi-dr.com

ABOUT DEL GLOBAL TECHNOLOGIES

Del Global Technologies Corp. is primarily engaged in the design, manufacture and marketing of high performance diagnostic imaging systems for medical, dental and veterinary applications through the Del Medical Systems Group. Through its U.S. based Del Medical Imaging Corp. and Milan, Italy based Villa Sistemi Medicali S.p.A. subsidiaries the Company offers a broad portfolio of general radiographic, radiographic/fluoroscopic, portable x-ray and digital radiographic systems to the global marketplace. Through its RFI subsidiary, Del Global manufactures proprietary high-voltage power conversion subsystems including electronic filters, high voltage capacitors, pulse modulators, transformers and reactors, and a variety of other products designed for industrial, medical, military and other commercial applications. The company's web site is www.delglobal.com.

Statements about future results made in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and the current economic environment. Del Global cautions that these statements are not guarantees of future performance. These statements involve a number of risks and uncertainties that are difficult to predict, including, but not limited to: the ability of Del Global to introduce products as scheduled; obtaining necessary product certification; implement its business plan; retention of management; changing industry and competitive conditions; obtaining anticipated operating efficiencies; securing necessary capital facilities; favorable determinations in various legal matters; market and operating risks from foreign currency exchange exposures; and favorable general economic conditions. Actual results could differ materially from those expressed or implied in the forward-looking statements. Important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements are specified in the Company's filings with the Securities and Exchange Commission.